BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF
79 results:

  • 1. Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals.
    Letafati A; Mozhgani SH; Marjani A; Amiri A; Siami Z; Mohammaditabar M; Molaverdi G; Hedayatyaghoobi M
    Med Oncol; 2023 Oct; 40(11):317. PubMed ID: 37792095
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of Potential Therapeutic Targets for Plasmablastic lymphoma Through Gene Expression Analysis: Insights into RAS and Wnt Signaling Pathways.
    Mansoor A; Kamran H; Akhter A; Seno R; Torlakovic EE; Roshan TM; Shabani-Rad MT; Elyamany G; Minoo P; Stewart D
    Mod Pathol; 2023 Aug; 36(8):100198. PubMed ID: 37105495
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Inhibition of Integrin α
    Huang L; Zhu Y; Kong Q; Guan X; Lei X; Zhang L; Yang H; Yao X; Liang S; An X; Yu J
    Cell Adh Migr; 2023 Dec; 17(1):1-14. PubMed ID: 36944577
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PAX5 P80R-mutated B-cell acute lymphoblastic leukemia with transformation to histiocytic sarcoma: clonal evolution assessment using NGS-based immunoglobulin clonality and mutation analysis.
    Kroeze LI; Scheijen B; Hebeda KM; Rijntjes J; Luijks JACW; Evers D; Hobo W; Groenen PJTA; van den Brand M
    Virchows Arch; 2023 Jul; 483(1):105-110. PubMed ID: 36241730
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Novel ALK-EML4 fusion with prominent mucous and hyaline stroma: Expanding the molecular genetic spectrum of S100 and CD34 positive spindle cell tumor.
    Sun R; Hu R; Xiong J; Wang Y
    Indian J Pathol Microbiol; 2022; 65(3):695-698. PubMed ID: 35900506
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy.
    Baranov E; Winsnes K; O'Brien M; Voss SD; Church AJ; Janeway KA; DuBois SG; Davis JL; Al-Ibraheemi A
    Histopathology; 2022 Aug; 81(2):215-227. PubMed ID: 35543076
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney.
    Tan SY; Al-Ibraheemi A; Ahrens WA; Oesterheld JE; Fanburg-Smith JC; Liu YJ; Spunt SL; Rudzinski ER; Coffin C; Davis JL
    Histopathology; 2022 Mar; 80(4):698-707. PubMed ID: 34843129
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Dual Role of Autophagy in Crizotinib-Treated ALK
    Espinos E; Lai R; Giuriato S
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685497
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tectorigenin regulates migration, invasion, and apoptosis in dexamethasone-induced human airway epithelial cells through up-regulating miR-222-3p.
    Qian X; Xiao Q; Li Z
    Drug Dev Res; 2021 Nov; 82(7):959-968. PubMed ID: 33543488
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The chaperone Hsp70 is a BH3 receptor activated by the pro-apoptotic Bim to stabilize anti-apoptotic clients.
    Guo Z; Song T; Wang Z; Lin D; Cao K; Liu P; Feng Y; Zhang X; Wang P; Yin F; Dai J; Zhou S; Zhang Z
    J Biol Chem; 2020 Sep; 295(37):12900-12909. PubMed ID: 32651234
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Kinome multigenic panel identified novel druggable EPHB4-V871I somatic variant in high-risk neuroblastoma.
    Andolfo I; Lasorsa VA; Manna F; Rosato BE; Formicola D; Iolascon A; Capasso M
    J Cell Mol Med; 2020 Jun; 24(11):6459-6471. PubMed ID: 32336043
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Novel PPP1CB-ALK fusion in spindle cell tumor defined by S100 and CD34 coexpression and distinctive stromal and perivascular hyalinization.
    Lopez-Nunez O; Surrey LF; Alaggio R; Fritchie KJ; John I
    Genes Chromosomes Cancer; 2020 Aug; 59(8):495-499. PubMed ID: 32222087
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects.
    Bentayeb H; Aitamer M; Petit B; Dubanet L; Elderwish S; Désaubry L; de Gramont A; Raymond E; Olivrie A; Abraham J; Jauberteau MO; Troutaud D
    J Exp Clin Cancer Res; 2019 Nov; 38(1):450. PubMed ID: 31684984
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemia.
    Song J; Yuan C; Yang J; Liu T; Yao Y; Xiao X; Gajendran B; Xu D; Li YJ; Wang C; Liu W; Wen M; Spaner D; Filmus J; Zacksenhaus E; Zhang Y; Hao X; Ben-David Y
    FEBS J; 2018 Dec; 285(24):4631-4645. PubMed ID: 30387554
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Up-regulation of microRNA-497 inhibits the proliferation, migration and invasion but increases the apoptosis of multiple myeloma cells through the MAPK/ERK signaling pathway by targeting raf-1.
    Ye CY; Zheng CP; Ying WW; Weng SS
    Cell Cycle; 2018; 17(24):2666-2683. PubMed ID: 30382763
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Inhibition of the raf-1 kinase inhibitory protein (RKIP) by locostatin induces cell death and reduces the CXCR4-mediated migration of chronic lymphocytic leukemia cells.
    Crassini K; Pyke T; Shen Y; Stevenson WS; Christopherson RI; Mulligan SP; Best OG
    Leuk Lymphoma; 2018 Dec; 59(12):2917-2928. PubMed ID: 29911936
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose- and time-dependent manner.
    Lohmeyer J; Nerreter T; Dotterweich J; Einsele H; Seggewiss-Bernhardt R
    Clin Exp Immunol; 2018 Jul; 193(1):64-72. PubMed ID: 29573266
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells.
    MacDonald RJ; Bunaciu RP; Ip V; Dai D; Tran D; Varner JD; Yen A
    Leuk Lymphoma; 2018 Dec; 59(12):2941-2951. PubMed ID: 29569971
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•craf interactions to upregulate BIM and circumvent drug resistance in lymphoma cells.
    Ding H; Peterson KL; Correia C; Koh B; Schneider PA; Nowakowski GS; Kaufmann SH
    Leukemia; 2017 Jul; 31(7):1593-1602. PubMed ID: 27890930
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Functional Implications of the spectrum of BCL2 mutations in lymphoma.
    Singh K; Briggs JM
    Mutat Res Rev Mutat Res; 2016; 769():1-18. PubMed ID: 27543313
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.